Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism

As a newly emerging metabolic regulator, accumulating evidence suggests that the circulating fibroblast growth factor 19 (FGF19) level correlated with lipid and glucose metabolism. Several independent groups have found that FGF19 was highly likely associated with multiple metabolic disorders. Thyroi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Lai, Yaxin, Wang, Haoyu, Xia, Xinghai, Wang, Zhaojun, Fan, Chenling, Wang, Hong, Zhang, Hongmei, Ding, Shuangning, Teng, Weiping, Shan, Zhongyan
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2016
Fag:
4300
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5265952/
https://ncbi.nlm.nih.gov/pubmed/27684859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005001
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker